| pubmed-article:8988734 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C1512162 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0227598 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0016980 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0020823 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0042670 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:8988734 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:8988734 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8988734 | pubmed:dateCreated | 1997-1-29 | lld:pubmed |
| pubmed-article:8988734 | pubmed:abstractText | This study was conducted to assess the efficacy and toxicity of vinblastine, ifosfamide, and gallium nitrate (VIG) as first-line chemotherapy in patients with locally advanced or metastatic carcinoma of the urothelium. | lld:pubmed |
| pubmed-article:8988734 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8988734 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8988734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8988734 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8988734 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8988734 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:8988734 | pubmed:author | pubmed-author:EinhornL HLH | lld:pubmed |
| pubmed-article:8988734 | pubmed:author | pubmed-author:RothB JBJ | lld:pubmed |
| pubmed-article:8988734 | pubmed:author | pubmed-author:LoehrerP JPJ | lld:pubmed |
| pubmed-article:8988734 | pubmed:author | pubmed-author:DreicerRR | lld:pubmed |
| pubmed-article:8988734 | pubmed:author | pubmed-author:PropertK JKJ | lld:pubmed |
| pubmed-article:8988734 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8988734 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:8988734 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:8988734 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8988734 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8988734 | pubmed:pagination | 110-4 | lld:pubmed |
| pubmed-article:8988734 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:meshHeading | pubmed-meshheading:8988734-... | lld:pubmed |
| pubmed-article:8988734 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:8988734 | pubmed:articleTitle | Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892). | lld:pubmed |
| pubmed-article:8988734 | pubmed:affiliation | Department of Medicine, University of Iowa, Iowa City, USA. | lld:pubmed |
| pubmed-article:8988734 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8988734 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8988734 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8988734 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8988734 | lld:pubmed |
